Reliability of an Algorithm to Diagnose Spasticity

Sponsor
Vanderbilt University (Other)
Overall Status
Completed
CT.gov ID
NCT01644123
Collaborator
Merz North America, Inc. (Industry)
72
3
33
24
0.7

Study Details

Study Description

Brief Summary

Spasticity is a condition that results from damage to the central nervous system and causes painful muscle contractures that drastically affect level of independence, activities of daily living, and quality of life. Although there are well-known and accepted treatments for spasticity, spasticity is often left undertreated; the specific reasons for this observation are unknown. Because there is no blood test or scan that indicates the presence of spasticity, diagnosis is based entirely on physician impression. Therefore, the investigators hypothesize that one reason that spasticity is undertreated is due to the lack of a standardized diagnostic procedure. This study attempts to test the reliability of a diagnostic flowchart that seeks to increase the accuracy of physician diagnosis of spasticity.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Spasticity is defined as a velocity-dependent increase in stretch reflex with muscle overactivity, and is associated with involuntary limb movements or spasms which can often be painful. Active function (such as walking, driving, writing, or sexual activity) can be adversely affected by spasticity. For patients with significant disability requiring a caregiver, passive function (such as facilitation of bathing, dressing, and undergarment change) can also become very difficult, especially when spasticity is left untreated. Finally, persistent involuntary motion or spasms may negatively impact an individual's mood or self image, making social situations more difficult and sometimes overwhelming.

    Spasticity is especially undertreated in vulnerable populations; population surveys in individuals with intellectual disability and nursing home residents have shown that less than 20% of affected individuals are treated. There are severe negative consequences of leaving spasticity untreated, like muscle shortening and tendon and soft tissue contractures. Once developed, contractures are very difficult to treat and can hinder personal hygiene and dressing, and well as the ability to sit or lie properly. Bad hygiene and immobility can lead, in turn, to urinary tract infections, pressure ulcers and skin breakdown. Furthermore, spasticity can stunt muscle growth and cause abnormal bone growth and formation, especially in children.

    Spasticity is diagnosed based upon a physician's clinical impression; there is currently no biomarker to facilitate an objective diagnosis. The two instruments most commonly used to document severity are the Modified Ashworth Scale and Range of Motion Assessment. Both assessments are based upon a clinician's assessment of muscle tone, but there is no widely-accepted protocol to determine the presence of spasticity. We therefore hypothesize one reason spasticity is widely undertreated is the challenge faced by physicians when attempting to make a diagnosis. In the absence of a biomarker, a more standardized method of clinical diagnosis is necessary, both for future research and for advocacy efforts. The treatment of spasticity could increase quality of life by allowing an individual to participate more independently in activities of daily living, and by making assistance easier for caregivers.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    72 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Inter-Rater Reliability of a Spasticity Diagnosis Algorithm
    Study Start Date :
    Apr 1, 2013
    Actual Primary Completion Date :
    Jan 1, 2016
    Actual Study Completion Date :
    Jan 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Nursing home residents

    Outcome Measures

    Primary Outcome Measures

    1. Inter-rater reliability of a spasticity diagnosis algorithm when used by two movement disorder specialists. [One year]

      Two movement disorders specialists will independently use the flowchart while performing physical and neurological examinations on enrolled patients to determine whether spasticity is present.

    Secondary Outcome Measures

    1. To compare the prevalence of spasticity between three nursing homes in Davidson County, Tennessee. [One year]

      We will attempt to estimate the prevalence of spasticity in the nursing home setting based on the prevalence observed in 3 randomly selected nursing homes in Middle Tennessee.

    2. Awareness of different spasticity treatments and treatment preferences (if treatment is applicable) based on a Treatment Preferences Survey. [One year]

      We will survey enrolled subjects to determine if they are aware of available treatments for spasticity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male and female subjects of any race, aged 18 and above.

    • Reside in one of the five selected long term care facilities.

    Exclusion Criteria:
    • Subjects for whom it is felt that participation in the study would cause medical harm.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tennessee State Veterans Home Murfreesboro Tennessee United States 37130
    2 Trevecca Health & Rehab Nashville Tennessee United States 37210
    3 Bethany Health & Rehabilitation Center Nashville Tennessee United States 37211

    Sponsors and Collaborators

    • Vanderbilt University
    • Merz North America, Inc.

    Investigators

    • Principal Investigator: David Charles, M.D., Vanderbilt University Medical Center
    • Principal Investigator: Thomas Davis, M.D., Vanderbilt University Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    David Charles, Vice-Chairman, Department of Neurology; Chief Medical Officer, Vanderbilt Neuroscience Institute, Vanderbilt University
    ClinicalTrials.gov Identifier:
    NCT01644123
    Other Study ID Numbers:
    • 090361
    • 090361
    First Posted:
    Jul 18, 2012
    Last Update Posted:
    Jan 26, 2016
    Last Verified:
    Jan 1, 2016
    Keywords provided by David Charles, Vice-Chairman, Department of Neurology; Chief Medical Officer, Vanderbilt Neuroscience Institute, Vanderbilt University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 26, 2016